Leukemia cutis (LC) and eosinophilic dermatosis of hematologic malignancy (EDHM) are rare cutaneous manifestations of hematologic malignancies. Various therapeutic options have been reported, with largely underwhelming responses. We present a patient with chronic lymphocytic leukemia (CLL) with concomitant LC and EDHM who was treated with dupilumab.
Recommended CitationJin, Annie; Pousti, Bobak T.; Savage, Kevin T.; Mollanazar, Nicholas K.; Lee, Jason B.; and Hsu, Sylvia, "Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia." (2019). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper 114.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.